Novartis Restructuring Continues as Pharmaceuticals Division Splits, along with Pharma CEO
Novartis Restructuring Continues as Pharmaceuticals Division Splits, along with Pharma CEO
SUGAR LAND--May 27, 2015--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--One of the Pharmaceutical-Biotech Industry's top three drug makers, Swiss-based Novartis International AG (NYSE:NVS) (Basel, has restructured its pharmaceuticals division by creating two business units--Novartis Pharmaceuticals and Novartis Oncology. Coinciding with the organizational split, the division head and chief executive officer of the company's Pharmaceuticals division, David Epstein, called it quits.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips